# TCAF2

## Overview
TCAF2 (TRPM8 channel associated factor 2) is a gene that encodes a regulatory protein involved in the modulation of the TRPM8 ion channel, a member of the transient receptor potential (TRP) channel family. The TRPM8 channel is primarily known for its role in sensing cold temperatures and menthol, contributing to thermosensation and pain perception. TCAF2 acts as an inhibitory factor, suppressing TRPM8 activity and influencing calcium ion flow and cellular signaling pathways. This regulatory function is crucial for maintaining physiological balance in sensory neurons and other tissues where TRPM8 is expressed (Ochoa2023Therapeutic; Hsieh2020Opposing). TCAF2 is expressed in various tissues, including the liver and prostate, and its expression levels can vary among different human haplogroups, suggesting a role in tissue-specific regulation of TRPM8 (Hsieh2020Opposing). Additionally, TCAF2 has been implicated in the progression of glioma, highlighting its potential as a therapeutic target in cancer treatment (Yun2023TCAF2).

## Function
TCAF2 (TRPM8 channel associated factor 2) is a protein that plays a significant role in modulating the activity of the TRPM8 ion channel, which is involved in sensing cold temperatures and menthol. TCAF2 acts as a regulatory factor that suppresses the activity of the TRPM8 channel, influencing calcium ion flow and cellular signaling pathways (Ochoa2023Therapeutic; Hsieh2020Opposing). This modulation is crucial for the physiological regulation of TRPM8 channel activity, which is important for thermosensation and pain perception in sensory neurons (Hsieh2020Opposing).

TCAF2 is highly expressed in liver and prostate tissues, particularly in specific cell clusters such as hepatocytes and prostate glandular and endothelial cells (Hsieh2020Opposing). The expression of TCAF2 varies between different human haplogroups, with the H5 haplogroup associated with increased expression in liver and prostate tissues, while the H4 haplogroup shows increased expression in thyroid and tibial nerve tissues (Hsieh2020Opposing). This differential expression suggests that TCAF2 may influence the regulation of TRPM8 in these tissues, potentially affecting thermal regulation and other physiological processes (Hsieh2020Opposing).

## Clinical Significance
TCAF2 (TRPM8 channel associated factor 2) has been implicated in the progression and prognosis of glioma, a type of brain tumor. Studies have shown that TCAF2 is upregulated in glioma, including glioblastoma multiforme (GBM) and low-grade glioma (LGG), compared to healthy brain tissue. This upregulation is associated with shorter overall survival in glioma patients, as confirmed by analyses of TCGA and CGGA-693 datasets (Yun2023TCAF2). TCAF2 expression correlates with clinicopathological features such as age, WHO grade, IDH status, and 1p/19q status, and is particularly elevated in higher-grade tumors and IDH wild-type patients (Yun2023TCAF2). Functionally, TCAF2 overexpression promotes glioma cell migration and invasion through epithelial-mesenchymal transition (EMT) processes and activation of the STAT3 signaling pathway. In vivo studies have demonstrated that TCAF2 overexpression decreases survival in a xenograft mouse model, indicating its role in enhancing glioma cell motility and reducing survival rates (Yun2023TCAF2). These findings suggest that TCAF2 could be a potential drug target for glioma therapy, highlighting the need for new treatment strategies targeting molecules like TCAF2 to prevent glioma progression (Yun2023TCAF2).

## Interactions
TCAF2 interacts with the TRPM8 ion channel, a member of the transient receptor potential (TRP) channel family, which is involved in sensing cold temperatures and menthol. This interaction is crucial for the regulation of TRPM8's trafficking and activity. TCAF2 binds to both the N-terminal and, to a lesser extent, the C-terminal tails of TRPM8, as demonstrated by GST pull-down assays and confirmed through immunoprecipitation experiments in HEK293 cells (Gkika2015TRP). The interaction between TCAF2 and TRPM8 was also validated using Förster resonance energy transfer (FRET) experiments, indicating a significant interaction in living cells (Gkika2015TRP).

TCAF2 has an inhibitory effect on TRPM8 activity, silencing the channel while retaining it in the plasma membrane (Gkika2015TRP). This regulatory role is distinct from that of TCAF1, which facilitates TRPM8 channel opening. TCAF2's interaction with TRPM8 is not limited to direct binding; it also influences the channel's physiological functions, such as cell migration, by promoting migration speed when TRPM8 is expressed (Gkika2015TRP).

In addition to its interaction with TRPM8, TCAF2 is suggested to interact with other TRP channels, such as TRPV6 and the short isoform of TRPM2, indicating a broader role in TRP channel regulation (Gkika2015TRP).


## References


[1. (Gkika2015TRP) Dimitra Gkika, Loic Lemonnier, George Shapovalov, Dmitri Gordienko, Céline Poux, Michela Bernardini, Alexandre Bokhobza, Gabriel Bidaux, Cindy Degerny, Kathye Verreman, Basma Guarmit, Mohamed Benahmed, Yvan de Launoit, Rene J.M. Bindels, Alessandra Fiorio Pla, and Natalia Prevarskaya. Trp channel–associated factors are a novel protein family that regulates trpm8 trafficking and activity. Journal of Cell Biology, 208(1):89–107, January 2015. URL: http://dx.doi.org/10.1083/jcb.201402076, doi:10.1083/jcb.201402076. This article has 84 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1083/jcb.201402076)

[2. (Ochoa2023Therapeutic) Sara V. Ochoa, Zulma Casas, Sonia L. Albarracín, Jhon Jairo Sutachan, and Yolima P. Torres. Therapeutic potential of trpm8 channels in cancer treatment. Frontiers in Pharmacology, March 2023. URL: http://dx.doi.org/10.3389/fphar.2023.1098448, doi:10.3389/fphar.2023.1098448. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphar.2023.1098448)

3. (Hsieh2020Opposing) Opposing selective forces operating on human-specific duplicated TCAF genes in Neanderthals and humans. This article has 2 citations.

[4. (Yun2023TCAF2) Debo Yun, Jianshen Liang, Xuya Wang, Jikang Fan, Xisen Wang, Jiabo Li, Xiao Ren, Jie Liu, Xiude Ren, Hao Zhang, Guanjie Shang, Wenzhe Jin, Lei Chen, Tao Li, Chen Zhang, Shengping Yu, and Xuejun Yang. Tcaf2 drives glioma cellular migratory/invasion properties through stat3 signaling. Molecular and Cellular Biochemistry, 479(7):1801–1815, November 2023. URL: http://dx.doi.org/10.1007/s11010-023-04891-0, doi:10.1007/s11010-023-04891-0. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s11010-023-04891-0)